A funding program for new anti-cancer drugs in Ontario, Canada, based on quality of evidence and a hierarchy of outcomes

被引：0
|
作者：
Evans, WK
Pater, J
Nefsky, N
Brouwers, M
Browman, G
Cowan, D
机构：
[1] Canc Care Ontario, Toronto, ON, Canada
[2] Queens Univ, Natl Canc Inst Canada Clin Trials, Kingston, ON, Canada
[3] McMaster Univ, Program Evidence Based Care, Hamilton, ON, Canada
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：300 / 301
页数：2
相关论文
共 50 条
  • [31] Occupational exposure to anti-cancer drugs: A review of effects of new technology
    Vyas, Nitin
    Yiannakis, Dennis
    Turner, Andrew
    Sewell, Graham J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (04) : 278 - 287
  • [32] Palmitoyl-acyltransferases as new targets for anti-cancer drugs.
    Ducker, CE
    Stettler, EM
    Smith, RA
    Griffel, LK
    Keller, SW
    Smith, CD
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9148S - 9148S
  • [33] Quinoline and imidazole dimers and their hybrids as new potential anti-cancer drugs
    Pottier, Laurent
    Le Calve, Benjamin
    De Neve, Nancy
    Nshimyumukiza, Prosper
    Dewelle, Janique
    Lefranc, Florence
    Mijatovic, Tatjana
    Kiss, Robert
    CANCER RESEARCH, 2009, 69
  • [34] THE ROLE OF AUSTRALIAN REGULATORY AUTHORITIES IN THE DEVELOPMENT OF NEW ANTI-CANCER DRUGS
    SNYDER, RD
    MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03): : 192 - 192
  • [35] Protein Quality Control Dysfunction in Cardiovascular Complications Induced by Anti-Cancer Drugs
    Fu, Hai Ying
    Mukai, Mikio
    Awata, Nobuhisa
    Sakata, Yasushi
    Hori, Masatsugu
    Minamino, Tetsuo
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (01) : 109 - 117
  • [36] Protein Quality Control Dysfunction in Cardiovascular Complications Induced by Anti-Cancer Drugs
    Hai Ying Fu
    Mikio Mukai
    Nobuhisa Awata
    Yasushi Sakata
    Masatsugu Hori
    Tetsuo Minamino
    Cardiovascular Drugs and Therapy, 2017, 31 : 109 - 117
  • [37] Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones
    Zec, Manja
    Srdic-Rajic, Tatjana
    Konic-Ristic, Aleksandra
    Todorovic, Tamara
    Andjelkovic, Katarina
    Filipovic-Ljeskovic, Ivana
    Radulovic, Sinisa
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (09) : 1071 - 1080
  • [38] The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries
    Sarah Kleijnen
    Teresa Leonardo Alves
    Kim Meijboom
    Iga Lipska
    Anthonius De Boer
    Hubertus G. Leufkens
    Wim G. Goettsch
    Quality of Life Research, 2017, 26 : 2479 - 2488
  • [39] The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries
    Kleijnen, Sarah
    Alves, Teresa Leonardo
    Meijboom, Kim
    Lipska, Iga
    De Boer, Anthonius
    Leufkens, Hubertus G.
    Goettsch, Wim G.
    QUALITY OF LIFE RESEARCH, 2017, 26 (09) : 2479 - 2488
  • [40] Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs
    Mustacchi, Giorgio
    Generali, Daniele
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) : 405 - 408
12345